https://doi.org/10.1016/j.apsb.2024.05.018
This new article publication from Acta Pharmaceutica Sinica B, discusses how SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites.

Viruses often manipulate ubiquitination pathways to facilitate their replication and pathogenesis. CUL2^ZYG11B known as the substrate receptor of cullin-2 RING E3 ligase, is bound by SARS-CoV-2 ORF10 to increase its E3 ligase activity, leading to degradation of IFT46, a protein component of the intraflagellar transport (IFT) complex B. This results in dysfunctional cilia, which explains certain symptoms that are specific to COVID-19.

However, the precise molecular mechanism of how ORF10 recognizes CUL2^ZYG11B remains unknown. The authors of this article determined the crystal structure of CUL2^ZYG11B complexed with the N-terminal extension (NTE) of SARS-CoV-2 ORF10 (2.9 Å). The structure reveals that the ORF10 N-terminal heptapeptide (NTH) mimics the Gly/N-degron to bind CUL2^ZYG11B. Mutagenesis studies identified key residues within ORF10 that are key players in its interaction with CUL2^ZYG11B both in ITC assay and in vivo cells. In addition, enhancement of CUL2^ZYG11B activity for IFT46 degradation by which ORF10-mediated correlates with the binding affinity between ORF10 and CUL2^ZYG11B was proven. Finally, a Global Protein Stability system was used to show that the NTH of ORF10 mimics the Gly/N-degron motif, thereby binding competitively to CUL2^ZYG11B and inhibiting the degradation of target substrates bearing the Gly/N-degron motif.

Overall, this study sheds light on how SARS-CoV-2 ORF10 exploits the ubiquitination machinery for proteasomal degradation, and offers valuable insights for optimizing PROTAC-based drug design based on NTH CUL2^ZYG11B interaction, while pinpointing a promising target for the development of treatments for COVID-19.

Keywords: SARS-CoV-2, ORF10, Crystal structure, cullin-2 RING E3 ligase, Drug design
Graphical Abstract: available at https://ars.els-cdn.com/content/image/1-s2.0-S2211383524001965-ga1_lrg.jpg
This paper studied a mechanism of SARS-CoV-2 ORF10 binding to CUL2^ZYG11B by mimicking Gly/N-degrons, revealing potential unique drug-targeting sites.
# # # # # #
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/
Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board

APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).

Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).

CiteScore: 22.4
Impact Factor: 14.7 (Top 5 journal in the category of Pharmacology and pharmacy)
JIF without self-citation: 13.9
ISSN 2211-3835
# # # # #
Kaixiang Zhu, Lili Song, Linyue Wang, Lei Hua, Ziyu Luo, Tongyun Wang, Bo Qin, Shuofeng Yuan, Xiaopan Gao, Wenyi Mi, Sheng Cui, SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites, Acta Pharmaceutica Sinica B, Volume 14, Issue 9, 2024, Pages 4164-4173, ISSN 2211-3835, https://doi.org/10.1016/j.apsb.2024.05.018